Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
NEWHOUSE PHARMACEUTICALS from Izegem, company number BE0687802947, closed financial year 2025 with a result of € 142,769 after tax. For that financial year NEWHOUSE PHARMACEUTICALS recorded a gross margin of € 243,266 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 112,764 to € 142,769. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 1.3 million
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 142,769
▲ 27% vs 2024
Profit after tax over the fiscal year.
€ 29,115
▲ € 29,013 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
28 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 1.3 million
▼ 7% vs 2024
€ 243,794 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 7,781
▼ 30% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 25,703
▼ 43% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 167,946 | € 225,817 | € 206,397 | € 243,266 | ▲ 18% |
| Profit after taxes | € 100,733 | € 123,333 | € 112,764 | € 142,769 | ▲ 27% |
| Equity | € 1,011,569 | € 1,109,901 | € 1,192,665 | € 1,295,433 | ▲ 9% |
| Total debts | € 1,631,754 | € 1,542,933 | € 1,466,425 | € 1,363,651 | ▼ 7% |
| Cash | € 21,347 | € 10,777 | € 102 | € 29,115 | ▲ € 29,013 |
| Retained profit | € 836,569 | € 934,901 | € 1,017,665 | € 1,120,433 | ▲ 10% |
| Dividend | € 50,000 | € 25,000 | € 30,000 | € 40,000 | ▲ 33% |
| Bank debt | € 1,534,944 | € 1,451,261 | € 1,364,646 | € 1,274,389 | ▼ 7% |
| Balance sheet total | € 2,643,323 | € 2,652,835 | € 2,659,089 | € 2,659,085 |
By gross margin, NEWHOUSE PHARMACEUTICALS ranks 22nd of 112 companies with main activity “Activiteiten van holdings” in Izegem that publish figures (fiscal year 2025).
Key figures of NEWHOUSE PHARMACEUTICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about NEWHOUSE PHARMACEUTICALS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to NEWHOUSE PHARMACEUTICALS?
What happened at NEWHOUSE PHARMACEUTICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 142,769 (▲ 27% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Izegem. KBO
In short
From € 100,733 profit in 2022 to € 142,769 profit in 2025.
Paid € 191,252 in corporate taxes since 2022.
Best year ever: 2025, with € 142,769 profit.
Paid out € 145,000 in dividends to the owners in total.
Management
Behind NEWHOUSE PHARMACEUTICALS is Thomas VANNIEUWENHUYSE. It owns 100% of Loma Pharma itself.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Meensesteenweg 82
8870 Izegem
Ten Bosstraat 5
8870 Izegem
Active since 11 January 2018
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Izegem
Same main activity (Activiteiten van holdings), 155 active companies in Izegem, largest first.
€ 6 million revenue · 2025
€ 4.3 million gross margin · 2025
€ 3.2 million revenue · 2025
€ 3 million revenue · 2025
€ 2.3 million revenue · 2025
€ 2.2 million gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VANNIEUWENHUYSE Thomas Willem Peter Igor Alexander(oprichter) 50.3%
- VANNIEUWENHUYSE Emile Thomas Michiel Rudolf(oprichter) 49.7%
Details
- Company number
- 0687.802.947
- VAT number
- BE 0687.802.947
- Registered office
- Meensesteenweg 82, 8870 Izegem
- Names & denominations
- NEWHOUSE PHARMACEUTICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2018
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Activiteiten van holdings
Holdings